- DrugWarRant.com, the longest running single-issue blog devoted to drug policy
Join us on Pete's couch.
Send comments, tips,
and suggestions to: Clinical trials for psychedelics need more convincing placebo treatments: 16-Sep-2026 -- UC San Francisco researchers are weighing in on one…
FDA hearing conducted for psychedelic drug trials: the FDA recently awarded priority review vouchers to two companies studying psilocybin for…
Use of betel nut by humans emerged 25,000 years ago: 9-Sep-2026 -- A team of Griffith University archaeologists has uncovered…
Psilocybin protects against nerve damage from chemotherapy: September 3, 2026 -- Chemotherapy is brutal. The cancer treatment is often lifesaving,…
Daily Archives: August 15, 2010
Drug Policy Science and the Blogosphere
Tim Condon, Ph.D., a Science Policy Advisor at the National Institute on Drug Abuse, guest posts at the ONDCP’s “blog.” With so much misinformation about drugs floating around the blogosphere, the National Institute on Drug Abuse (NIDA) re-launches its annual … Continue reading
Posted in Uncategorized
15 Comments
Don’t Over-Analyze Prop. 19
Because you can count on it: the mainstream media won’t analyze it at all Guest Post to Drug WarRant by KATE WOODS There has been a jungle of growing chatter within the pro-cannabis community over the issue of Proposition 19, … Continue reading
Posted in Uncategorized
40 Comments
A very timely and legally astute analysis on how federal rescheduling shifts the landscape for state-level defamation claims and commercial…